About Resilience
Resilience is a Healthcare company based in San Diego (United States) founded in 1995. Supply chain services for biopharma sector are provided. It operates on a Professional Services and Managed Services model. Resilience has raised $1.99 billion across 11 funding rounds from investors including HHS, Mubadala and Arch Venture Partners. Resilience has completed 2 acquisitions, including Ology Bio and Swift Scale Bio. Its chief executive, as recorded, is Rahul Singhvi. Its website resilience.com draws about 18 thousand monthly visits. Resilience offers products and services including Sprout Solutionsâ„¢, DAR-Tâ„¢, Essential AAV & LVV, and Idea to Clinicâ„¢. Its focus areas include Biotechnology and Biomanufacturing. Its legal entity is National Resilience, LLC. Its competitors include McKesson, PAR Excellence and ASP Isotopes.
Company details
Resilience is established as a contract development and manufacturing organization (CDMO) specializing in biologics, cell therapy, and gene therapy. Services are provided across various sectors including vaccines, viral vectors, and nucleic acids. End-to-end solutions are offered for development, scale-up, and tech transfer, ensuring speed and flexibility. Facilities are located throughout North America, supporting global markets in the EU, Asia, and the Middle East. Innovation is driven through partnerships and advanced technologies to enhance access to complex medicines.
- Headquarters San Diego, United States
- SectorsHealthcare
- Email••••••••
- Website resilience.com
- Social LinkedIn
- Legal Name National Resilience, Llc
Products & Services of Resilience
Resilience offers a comprehensive portfolio of products and services, including Sprout Solutions™, DAR-T™, Essential AAV & LVV, and Idea to Clinic™.
Drug substance and fill/finish are supported with transparency.
Autologous CAR-T manufacturing is completed in three days.
Viral vector batches are produced within twelve months.
Biologic development to clinic is accelerated by 30%.
Funding Insights of Resilience
Resilience has successfully raised a total of $1.99B across 11 strategic funding rounds. The most recent funding activity was a Debt – Conventional round of $825 million completed in October 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $1.99B
- Total Rounds 11
- Last Round Debt – Conventional — $825M
- First Round $10M
(Apr 2006)
- Investors Count 12
Latest 10 of 11 funding rounds of Resilience with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct 2025 | $825M | Debt – Conventional | – | – | |
| Oct 2024 | $17.5M | Grant | – | – | – |
| Mar 2023 | $410M | Debt – Conventional | – | – | |
| Jan 2023 | Series D | – | Mubadala | – | |
| Jun 2022 | $625M | Series D | – | – | – |
| Aug 2021 | $600M | Series C | – | – | – |
| Nov 2020 | $755M | Series B | – | Arch Venture Partners, 8VC | |
| Sep 2011 | $1.4M | Grant | – | – | |
| Apr 2011 | $3.57M | Grant | – | – | |
| Jun 2010 | $595,945 | Grant | – | – |
12 investors in total: 12 institutional.
Investors in Resilience
Resilience has secured backing from 12 investors, including institutional and venture fund investors. Prominent investors backing the company include HHS, Mubadala and Arch Venture Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Government agency supporting the development of SMEs | 2019 | dfc.gov | ||
Venture capital firm focused on life science companies | 1986 | archventure.com | Chicago, United States | |
Venture capital firm investing in technology, life sciences, and related sectors. | 8vc.com | |||
Corporate backed venture capital fund investing in multiple sectors | gv.com | Mountain View, United States | ||
Venture capital investments are offered to startups by NEA. | nea.com | Menlo Park, United States | ||
Tech and offline focused VC firm investing primarily in the US and Europe | 1997 | kennet.com | London, United Kingdom | |
Private equity and real estate investment firm | 1997 | bpeasia.com | Beijing, China | |
Diversified debt funds are managed across asset classes and geographies. | oakhilladvisors.com | |||
Military forces are provided by the U.S. Department of Defense for national security. | defense.gov | Washington, D.C., United States | ||
Sovereign wealth fund of United Arab Emirates | 2002 | mubadala.com | Abu Dhabi, United Arab Emirates |
Investor details for Resilience
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Resilience
25 people are tracked at Resilience (8 in leadership, 16 in board & advisors, 1 in team).
| Name | Role | Group |
|---|---|---|
Rahul Singhvi | CEO & Director | Leadership |
Junan Guo | Chief Quality Officer | Leadership |
William S. Marth | President & CEO | Leadership |
Jimmy Wang | Chief Information Officer | Leadership |
Andrew Montone | Chief Financial Officer, Interim | Leadership |
Susan Billings | Chief Commercial Officer | Leadership |
Ori Solomon | Chief Legal Officer | Leadership |
Mara Strandlund | Chief People Officer | Leadership |
Robert Nelsen | Chairman | Board & advisors |
Beverly L. Davidson | Advisor | Board & advisors |
Mark McClellan | Advisor | Board & advisors |
George Barrett | Board Member | Board & advisors |
Joseph Robert Kerrey | Board Member | Board & advisors |
Mitchell E. Daniels | Board Member | Board & advisors |
Charlie Cooney | Advisor | Board & advisors |
Drew Oetting | Board Member | Board & advisors |
Frances Arnold | Board Member | Board & advisors |
Patrick Y. Yang | Vice Chairman | Board & advisors |
David Schenkein | Advisor | Board & advisors |
Scott Gottlieb | Board Member | Board & advisors |
5 more people are available in the full profile.
Complete people profiles for Resilience
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Resilience
Resilience has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include Ology Bio and Swift Scale Bio.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Cell-free protein synthesis platform for antibody treatments is developed. | swiftscalebio.com | San Francisco, United States | 2019 | Dec 2021 | •••• | |
Biologics-focused contract development and manufacturing organization (CDMO) | ologybio.com | Alachua, United States | 1999 | Apr 2021 | •••• |
Complete acquisition details for Resilience
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Resilience
5 dated milestones of Resilience across 30 years, from founding to its latest funding, stage changes and deals.
- Founded Resilience is founded.
- Funding First funding round of $10.0M.
- Acquisition Acquires Ology Bio.
- Acquisition Acquires Swift Scale Bio.
- Funding Latest funding round, Debt – Conventional, of $825.0M.
Competitors of Resilience
Resilience has 3 listed competitors in our database. They include McKesson, PAR Excellence and ASP Isotopes.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| mckesson.com | 1833 | Irving, United States | 51,000 | Products and services are provided in the healthcare industry. | ||
| parexcellence.com | 1997 | Cincinnati, United States | Supply chain logistics services are provided for the biopharma sector. | |||
| aspisotopes.com | 2021 | Boca Raton, United States | 4 | Supply chain solution services for isotope production are provided. |
Detailed competitors of Resilience
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Resilience
The website of Resilience (resilience.com) receives about 17.6K visits a month.
- Monthly visits17.6K
▲ 9.3% vs previous month
Websites whose visitors overlap most with Resilience. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| 3com.com | 100% | 1.4K | #13,568,447 | View details | |
| google.com | 72% | 85.8B | #1 | View details | |
| linkedin.com | 68% | 1.9B | #18 | View details | |
| sofaware.com | 66% | View details | |||
xnet.com.pk | xnet.com.pk | 66% | – | ||
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 27 similar websites and full traffic analytics for Resilience
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 27 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Biopharma Outsourcing & Drug Delivery
3 companies that operate in the same segment as Resilience (Biopharma Outsourcing & Drug Delivery) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 220 M | USD 374.1 M | 5,666 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Resilience
Complete news archive for Resilience
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Resilience
Resilience was founded in 1995 and raised its 1st funding round 11 years after it was founded.
Resilience is headquartered in San Diego, United States. It is registered at San Diego, California, United States.
Rahul Singhvi is the CEO of Resilience, as recorded in our data.
Resilience is a funded company, having raised a total of $1.99B across 11 funding rounds to date. The company's 1st funding round was a Grant of $595.95K, raised on Apr 2006.
Resilience is established as a contract development and manufacturing organization (CDMO) specializing in biologics, cell therapy, and gene therapy. Services are provided across various sectors including vaccines, viral vectors, and nucleic acids. End-to-end solutions are offered for development, scale-up, and tech transfer, ensuring speed and flexibility. Facilities are located throughout North America, supporting global markets in the EU, Asia, and the Middle East. Innovation is driven through partnerships and advanced technologies to enhance access to complex medicines.
Resilience's top competitors include McKesson, ASP Isotopes and PAR Excellence.
Resilience offers Sprout Solutionsâ„¢, DAR-Tâ„¢, Essential AAV & LVV, and Idea to Clinicâ„¢.
Resilience has made 2 acquisitions, including Ology Bio, and Swift Scale Bio.
Resilience has 12 investors. Key investors include HHS, Mubadala, Arch Venture Partners, Kennet Partners, and DFC.
Resilience operates through National Resilience, Llc.